Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2011-04-26
2011-04-26
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C544S253000
Reexamination Certificate
active
07932240
ABSTRACT:
Provided herein are phosphadiazine polymerase inhibitor, for example, of any of Formulas IV, IV′, I″, II″, or IVa, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
REFERENCES:
patent: 1 634 886 (2006-03-01), None
patent: 1634886 (2006-03-01), None
PCT ISA/EP International Search Report dated Jan. 21, 2009, for International Application No. PCT/US2008/010225. filed Aug. 28, 2008.
PCT ISA/EP International Written Opinion dated Jan. 21, 2009, for International Application No. PCT/US2008/010225. filed Aug. 28, 2008.
Palacios et al., Tetrahedron (1999), 55(10), 3091-3104.
Palacios et al., Tetrahedron (2005), 61(5), 1087-1094.
Palacios et al., Tetrahedron Letters (2002), 43(34), 5917-5919.
Yu et al., Zhurnal Obshchei Khimii (1993), 63(9), 1976-89.
English abstract of C4, 1993.
Alcaraz, G.; Baceiredo, A.; Nieger, M.; Schoeller, W. W.; Bertrand, G. Inorg. Chem. 1996, 35, 2458-2462.
Dmitrichenko et al., Russian Journal of General Chemistry, (1995), vol. 65, No. 3, Part 1.
Ashley, G. W.; Bartlett, P. A. Biochem. Biophys. Res. Commun. 1982, 108, 1467-1474.
Barluenga, J.; Lo'pez, F.; Palacios, F. Tetrahedron Lett. 1987, 28, 2875-2878.
Ried, W.; Fulde, M.; Bats, J. W. Helv. Chim. Acta 1990, 73, 1888-1893.
Pushechnikov et al., Khimiya Geterotsiklicheskikh Soedinenii (2001), No. 5, pp. 708-710.
English equivalent of C11, 2001.
Dousson Cyril
Paparin Jean-Laurent
Pierra Claire
Roland Arlène
Surleraux Dominique
Idenix Pharmaceuticals Inc.
Jones Day
Shiao Rei-tsang
LandOfFree
Phosphadiazine HCV polymerase inhibitors IV does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphadiazine HCV polymerase inhibitors IV, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphadiazine HCV polymerase inhibitors IV will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2684976